Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100T3FG
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 114
MetricValuePeriodScopeSource row
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31dCons.Net assets
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31Cons.Number of employees
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2023-12-31109 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,272
ItemContextValueUnit
Address major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)東京都港区
Name major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)BOFAS INC SEGREGATION ACCOUNT(常任代理人 BOFA証券株式会社)
Address major shareholdersCurrentYearInstant_No2MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)黒田 典宏
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)福井県丹生郡越前町
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)伊藤 輔則
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)千葉県船橋市
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)松井証券株式会社
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)東京都千代田区麹町１丁目４番地
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)野村證券株式会社
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋１丁目１３番１号
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)P.O.BOX 351 BOSTON MASSACHUSETTS02101 U.S.A.(東京都港区港南２丁目１５－１)
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)株式会社SBI証券
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)東京都港区六本木１丁目６番１号
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)10 HAREWOOD AVENUE LONDON NW1 6AA(東京都中央区日本橋３－１１－１)
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)モルガン・スタンレーMUFG証券株式会社
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)東京都千代田区大手町１丁目９番地７号
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は、100株であります。
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)１単元(100株)未満の株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese) シンバイオ製薬株式会社
Address of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)東京都港区虎ノ門四丁目１番２８号
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with audit and supervisory committee (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember
Original text (Japanese)代表取締役社長執行役員(CEO)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember
Original text (Japanese)吉 田 文 紀
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember1949-01-19
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember
Original text (Japanese)松本 茂外志
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember1949-08-12
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMember
Original text (Japanese)ブルース・デビッド・ チェソン

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass